Skip to main content
OpenTrials

Clinical trial condition

Congenital Abnormalities

Explore clinical trials studying Congenital Abnormalities. Study availability and eligibility vary by location and protocol.

5,341 public trials 1,076 recruiting studies
Refine in advanced search Browse all conditions

Congenital Abnormalities trial results

Completed

Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

NCT00876863

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View Trial Details
Completed

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

NCT00600275

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Faber Cancer Institute Boston, Massachusetts, United States
  • Nevada Cancer Center Las Vegas, Nevada, United States
  • Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States
View Trial Details
Completed

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

NCT01928459

Conditions
Acrocephalosyndactylia, Advanced Solid Tumors, Bone Diseases, +18 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States
  • Washington University School of Medicine Onc Dept St Louis, Missouri, United States
View all 22 locations
View Trial Details
Completed

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

NCT01428297

Conditions
Abnormalities, Multiple, Atopic Dermatitis, Congenital Abnormalities, +19 more
Locations
  • Novartis Investigative Site New Haven, Connecticut, United States
  • Novartis Investigative Site St Louis, Missouri, United States
  • Novartis Investigative Site Fargo, North Dakota, United States
  • Novartis Investigative Site Utrecht, The Netherlands, Netherlands
View Trial Details
Completed

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

NCT01482143

Conditions
Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Nashville, Tennessee, United States
  • Novartis Investigative Site Sant Cugat del Vallès, Catalonia, Spain
View Trial Details
Completed

A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure

NCT03563391

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +8 more
Locations
  • Nemours Children's Specialty Care Jacksonville, Florida, United States
  • GI Care for Kids Atlanta, Georgia, United States
  • East Carolina University Greenville, North Carolina, United States
  • Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details

Related conditions